These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20378721

  • 1. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome.
    Libé R, Coste J, Guignat L, Tissier F, Lefebvre H, Barrande G, Ajzenberg C, Tauveron I, Clauser E, Dousset B, Bertagna X, Bertherat J, Groussin L.
    Eur J Endocrinol; 2010 Jul; 163(1):129-38. PubMed ID: 20378721
    [Abstract] [Full Text] [Related]

  • 2. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.
    de Miguel V, Redal MA, Viale ML, Kahan M, Glerean M, Beskow A, Fainstein Day P.
    Medicina (B Aires); 2010 Jul; 70(3):254-6. PubMed ID: 20529775
    [Abstract] [Full Text] [Related]

  • 3. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
    Tatsuno I, Uchida D, Tanaka T, Koide H, Shigeta A, Ichikawa T, Sasano H, Saito Y.
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
    [Abstract] [Full Text] [Related]

  • 4. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome.
    de Groot JW, Links TP, Themmen AP, Looijenga LH, de Krijger RR, van Koetsveld PM, Hofland J, van den Berg G, Hofland LJ, Feelders RA.
    Eur J Endocrinol; 2010 Aug; 163(2):293-9. PubMed ID: 20460422
    [Abstract] [Full Text] [Related]

  • 5. Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas.
    Vassiliadi DA, Ntali G, Stratigou T, Adali M, Tsagarakis S.
    Endocrine; 2011 Dec; 40(3):437-44. PubMed ID: 21598069
    [Abstract] [Full Text] [Related]

  • 6. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide.
    Iida K, Kaji H, Matsumoto H, Okimura Y, Abe H, Fujisawa M, Kamidono S, Chihara K.
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):739-45. PubMed ID: 9497882
    [Abstract] [Full Text] [Related]

  • 7. Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors.
    Christopoulos S, Bourdeau I, Lacroix A.
    Horm Res; 2005 Dec; 64(3):119-31. PubMed ID: 16215323
    [Abstract] [Full Text] [Related]

  • 8. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
    Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H.
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
    [Abstract] [Full Text] [Related]

  • 9. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors.
    Vezzosi D, Cartier D, Régnier C, Otal P, Bennet A, Parmentier F, Plantavid M, Lacroix A, Lefebvre H, Caron P.
    Eur J Endocrinol; 2007 Jan; 156(1):21-31. PubMed ID: 17218722
    [Abstract] [Full Text] [Related]

  • 10. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.
    Nakamura Y, Son Y, Kohno Y, Shimono D, Kuwamura N, Koshiyama H, Sasano H, Matsuda T.
    Endocrine; 2001 Jun; 15(1):57-61. PubMed ID: 11572327
    [Abstract] [Full Text] [Related]

  • 11. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
    Miyamura N, Taguchi T, Murata Y, Taketa K, Iwashita S, Matsumoto K, Nishikawa T, Toyonaga T, Sakakida M, Araki E.
    Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
    [Abstract] [Full Text] [Related]

  • 12. Adrenal Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: prediction of the efficacy of beta-blockade therapy and interest of unilateral adrenalectomy.
    Mazzuco TL, Chaffanjon P, Martinie M, Sturm N, Chabre O.
    Endocr J; 2009 Dec; 56(7):867-77. PubMed ID: 19564707
    [Abstract] [Full Text] [Related]

  • 13. Cushing's syndrome secondary to ACTH-independent macronodular adrenal hyperplasia.
    Costa MH, Lacroix A.
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1226-37. PubMed ID: 18209860
    [Abstract] [Full Text] [Related]

  • 14. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.
    Mazzuco TL, Thomas M, Martinie M, Cherradi N, Sturm N, Feige JJ, Chabre O.
    Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1452-62. PubMed ID: 18209887
    [Abstract] [Full Text] [Related]

  • 15. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
    Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J.
    N Engl J Med; 1992 Oct 01; 327(14):981-6. PubMed ID: 1325609
    [Abstract] [Full Text] [Related]

  • 16. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension.
    Lacroix A, Tremblay J, Touyz RM, Deng LY, Lariviere R, Cusson JR, Schiffrin EL, Hamet P.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2414-22. PubMed ID: 9253310
    [Abstract] [Full Text] [Related]

  • 17. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome.
    Bourdeau I, D'Amour P, Hamet P, Boutin JM, Lacroix A.
    J Clin Endocrinol Metab; 2001 Nov 01; 86(11):5534-40. PubMed ID: 11701732
    [Abstract] [Full Text] [Related]

  • 18. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
    Daidoh H, Morita H, Hanafusa J, Mune T, Murase H, Sato M, Shibata T, Suwa T, Ishizuka T, Yasuda K.
    Clin Endocrinol (Oxf); 1998 Sep 01; 49(3):403-9. PubMed ID: 9861334
    [Abstract] [Full Text] [Related]

  • 19. ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
    Hofland J, Hofland LJ, van Koetsveld PM, Steenbergen J, de Herder WW, van Eijck CH, de Krijger RR, van Nederveen FH, van Aken MO, de Groot JW, Links TP, de Jong FH, Feelders RA.
    Orphanet J Rare Dis; 2013 Sep 13; 8():142. PubMed ID: 24034279
    [Abstract] [Full Text] [Related]

  • 20. Two cases of Cushing's syndrome due to primary bilateral macronodular adrenal hyperplasia secondary to aberrant adrenal expression of hormone receptors.
    Juliá-Sanchis MLL, Navarro-Téllez MDP, Falcones-Gracia KV, Ricart-Álvarez E, González-Bueno MV, Molina-Gasset R.
    Clin Biochem; 2018 Sep 13; 59():86-89. PubMed ID: 29936051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.